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Abstract 
Background: Linear headache (LH) has recently been described as a paroxysmal or continuous fixed head pain 
restricted in a linear trajectory of 5–10 mm in width, linking one endpoint in occipital or occipitocervical region with 
another endpoint in ipsilateral nasion or forehead region. For some patients, this headache had some features resem‑
bling migraine without aura.
Methods: We made a prospective search of patients presenting with a clinical picture comprised under the head‑
ing of LH and we have accessed eight new cases. A detailed clinical feature of the headache was obtained in all cases 
to differentiate with cranial neuralgia, paroxysmal hemicrania, cervicogenic headache, nummular headache and 
migraine.
Results: The eight LH patients complained of a recurrent moderate to severe, distending, pulsating, or pressure‑like 
pain within a strictly unilateral line‑shaped area. The headache duration would be ranged from 1 h to 2 days or persis‑
tent for 1–6 months with recurrent worsening of headaches. For some patients, this headache had couple of features 
similar to that of migraine pattern, such as accompaniments of nausea, vomiting, and phonophobia, diziness, trigger‑
ing factors of noise, bright night, resting after physical activity, fatigue, menstruation, and response to anti‑migraine 
therapy.
Conclusions: This description reinforces the proposal of LH as a new headache syndrome or a new variant of a previ‑
ously known headache syndrome, probably of migraine.
Keywords: Linear headache, Epicrania fugax, Cranial neuralgia, Paroxysmal hemicrania, Nummular headache, 
Cervicogenic headache, Migraine
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Background
Linear headache (LH) may represent a new headache 
syndrome or a variant of migraine as proposed recently 
based on the clinical features of twelve patients who 
presented with a paroxysmal or chronic fixed head pain 
restricted in a linear trajectory linking the occipital or 
occipitocervical region with the ipsilateral nasion or 
forehead region (Wang et  al. 2014b). In some patients, 
this head pain was accompanied with nausea, vomitting 
and dizziness. The attacks were spontaneous in most 
patients, but could also be triggered by noise, stress, 
staying up late, or resting after physical activity in some 
other patients. The paroxysms lasted for hours to days 
in most patients, but for minutes in some rare patients, 
and their character was described as pulsating, distend-
ing or pressure-like. Pain intensity was usually moderate 
or severe. The frequency of attacks was variable, from 
one attack per day to five or six attacks per year. Some 
patients had long-term remission course, while oth-
ers experienced no remission. The patients’s head pain 
improved with preventive medications, such as flunar-
izine, sodium valproate and amitriptyline but not to car-
bamazepine or oxcarbazepine (Wang et al. 2014b). Since 
the first description of LH case series, only one more case 
of LH-like head pain has been reported but it was associ-
ated with epicrania fugax (EF) (Pareja and Bandres 2015). 
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Here we describe eight new cases with the same clini-
cal features and their therapeutic responses to different 
medications.
Methods
After the publication of the first series of LH patients in 
June 2014 (Wang et al. 2014b), we started to make a pro-
spective search of new patients presenting with a clinical 
picture comprised under the heading of LH. Specifically, 
we aimed to record all patients complaining of fixed pain 
circumscribed in a linear trajectory bridging the poste-
rior and anterior cephalic regions, at the outpatient office 
of our Neurology department. Whenever we encoun-
tered a patient whose clinical presentations could fulfill 
the criteria for LH, all the clinical data including clinical 
presentations, neurological examinations, supplemental 
examinations and following up for therapeutic responses 
were registered systematically. This study started from 
April 2014 when the first report of LH case series was 
submitted to Dec 2015 when the current report was pre-
pared for submission.
A detailed history was obtained in all cases and a spe-
cial attention was paid to medical history of head trauma 
or macroscopic changes of the scalp. Patients were asked 
to point out the exact location of the pain-affecting area 
and to delineate it in size and shape. The pain characteris-
tics were carefully assessed, including the spatial features 
(trajectory distribution), the temporal features (duration 
and frequency), pain character and intensity at baseline 
and during exacerbations, and pain accompaniments. 
The presence of any triggering or facilitating factors or 
interictal symptoms was also evaluated. A complete 
physical and neurological examination was performed in 
all cases. Inspection, palpation and sensory examination 
of the affecting area, as well as palpation of the supraor-
bital, infraorbital, minor occipital and greater occipital 
nerves were included in the examination. Routine blood 
work-up with erythrocyte sedimentation rate, computed 
tomography (CT) or magnetic resonance imaging (MRI) 
of the head were performed in all cases to exclude any 
underlying disease. Cervical vertebra MRI or X-ray was 
also taken in all patients to check out the lesions which 
may cause cervicogenic headache (CEH) whose pain 
maps in very rare cases were described as linear area sim-
ilar to that in LH (Cooper et al. 2007).
The cervical flexion–rotation test (FRT), which has 
been proven to be a valid and reliable test of upper cervi-
cal movement impairment associated with CEH (Ogince 
et al. 2007; Hall et al. 2008, 2010a, b; Bravo Petersen and 
Vardaxis 2015), was specifically conducted to exclude the 
potential CEH as suggested in a reader’s comment on 
the first publication of LH case series (Kinney 2014). The 
manipulation of FRT was adapted from Hall’s method 
(Hall et  al. 2010b). Briefly, the patient was relaxed in 
supine and the cervical spine was pre-positioned in 
maximal end range flexion, then the head was passively 
rotated to the left and the right. End of the head rotation 
range was determined either by firm resistance encoun-
tered by the examiner or by the onset of pain reported 
by the patient, whichever came first. A compass attached 
to the apex of the head by straps was used to record the 
rotation range to determine whether the FRT was posi-
tive [range reduced more than 10° from the normal range 
of 44° (Hall and Robinson 2004; Ogince et  al. 2007)] or 
negative. Diagnosis of other concomitant headache syn-
dromes was based on the 3rd Edition of The International 
Headache Classification (ICHD-3) criteria (IHS 2013).
All patients accepted treatments. Three of them 
received flunarizine alone in dose of 5  mg twice a day, 
two of them tried successively flunarizine 5  mg twice a 
day and increasing doses of venlafaxine, and the other 
three patients took sodium valproate alone in dose of 
500 mg twice a day or successive flunarizine, venlafaxine 
and pregabalin.
Ethics
The study has been approved by the Ethics Committee of 
the Anhui Medical University within which the work was 
undertaken. All participants gave a written consent.
Results
Through a 20-month period (from April 2014 to Dec 
2015), eight patients with LH attended our Neurologi-
cal department at the first Hospital of Anhui Medical 
University. The demographic and clinical features of our 
eight patients are shown in Table  1. Among the eight 
patients (Table  1), six was female and two male. They 
were aged 32–74 years (mean 49.6 ± 15.3 years), and the 
age at onset of the paroxysmal or continuous head pain 
ranged from 32 to 73  years (mean 43.63  ±  17.5  years). 
One patient (patient 7) had personal and family history 
of migraine headaches. However, there was no temporal 
connection between the migraine headache and the cur-
rently reported head pain in this patient. Other seven 
patients had no other types of recurrent headaches. 
Apart from that, past medical history was unremarkable 
in all patients.
All patients complained of strictly unilateral parox-
ysmal or continuous head pain which almost invariably 
recurred on the same side. Five patients had symptoms 
on the left and two patients on the right, while the attacks 
shifted sides in only one patient. All patients reported 
gradual onset of pain among a linear trajectory of 5 mm 
to 10 mm in width, linking the occipital or occipitocervi-
cal region with the ipsilateral nasion or forehead region. 
No patient reported radiation or moving of the pain 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Page 4 of 10Lu et al. SpringerPlus  (2016) 5:347 
along the linear trajectory. The pain attack duration 
would be 1 h to 2 days in six patients, but persistent for 
1–6 months in two patients of whom one had episode of 
pain worsening for 1–3 h. The pain character was pulsat-
ing or distending in most cases, but pressure-like in one 
patient and aching pain in another one patient, among 
these two patients, one also had pulsating feature and 
another one also distending feature sometimes. The pain 
character was indescribable in one patient. All patients 
denied that the pain was epicranial but complained it 
intracranial. During the attack, accompanied nausea 
without vomiting was reported in two patients, ipsilateral 
or bilateral dizziness reported in two patients, ipsilat-
eral or bilateral temporal mild pain in three patients and 
desire to defecate in one patient, while no accompanied 
symptom reported in two patients. The paroxysms were 
usually spontaneous in four cases, but triggered by noise 
and bright light in one case, by noise and resting after 
physical activity in one case, by fatigue in one case and 
by menstruation in one case. During the interictal period, 
six patients had no symptoms at all, the other two had 
persistent LH pain. The frequency of attacks was vari-
able, ranging from one attack every 2–3  months to one 
attack per day. The temporal pattern of the attacks was 
chronic in four patients who had been having attacks for 
1–20 years without a remission. One patient had a remis-
sion period of 1  year between recurrent periods. The 
remaining three patients had short symptomatic period 
of half to 1 month and the pain was persistent or recur-
rent every day.
With regard to examinations, no skin change was noted 
along the painful linear trajectory either during the ictal 
period or during the interictal period in all patients, but 
a hyperaesthesia to light touch noted along the painful 
linear trajectory in one patient (patient 2). Regional mild 
pain was noted in two patients while palpating the greater 
occipital nerves (patient 2 and 4), but no abnormal sensa-
tion noted in all other patients. Neurological examina-
tion, brain CT or MRI, and blood tests were normal in all 
patients. Cervical MRI or X-ray results revealed no spe-
cial in almost all patients except in one patient (patient 1) 
who had degenerative changes of cervical vertebra. FRT 
results were negative in almost all patients except in one 
patient (patient 1) whose head rotation ranges to both 
sides were positive (range reduced more than 10° from 
the normal range of 44°).
Before coming to our department, 5 out of the 8 
patients had ever tried analgesics while the headache was 
attacking. 2 patients (patient 2 and 3) could not remem-
ber what the exact analgesics they had ever taken. 2 
patients (patient 1 and 5) had ever tried analgesics con-
sisting of aminopyrine, phenacetin, caffeine and pheno-
barbital, and the pain was alleviated mildly in one patient 
(patient 1) but not in another one (patient 5). One patient 
(patient 4) had ever tried indomethacin and the pain was 
not reduced. All these 5 patients abandoned the medica-
tions after trying couple of times. Regarding therapy after 
they came to our department, eight patients accepted 
prophylatic treatment and had good responses. Two 
patients (patient 6 and 8) treated with flunarizine (5 mg 
twice a day) alone had the headache recurrence pre-
vented and stopped taking medicine after 1 month treat-
ment. Three months later, the headache recurred in one 
patient (patient 8). Three other patients (patients 1, 2 and 
7) also took flunarizine (5 mg twice a day) alone first, and 
among these three patients, pain frequency and intensity 
was reduced in one patient (patient 7), but not changed 
in the other two patients (patients 1 and 2) who were fur-
ther added with venlafaxine (from 75  mg once a day to 
150  mg once a day) with pain recurrence prevented in 
one patient (patient 1) and pain frequency and intensity 
reduced in another one patient (patient 2). Sodium val-
proate (500 mg twice a day) alone relieved the LH pain in 
one patient (patient 5) but only reduced the pain sever-
ity in another one patient (patient 3) who was then added 
with flunarizine (5  mg twice a day) and had the non-
menstral pain prevented but menstral pain unchanged. 
For the last patient (patient 4), sodium valproate (500 mg 
twice a day) alone, sodium valproate (500 mg twice a day) 
together with flunarizine (5 mg twice a day), or venlafax-
ine (from 75 mg once a day to 150 mg once a day) alone 
failed to relieve the pain, but venlafaxine (150 mg once a 
day) in combination with pregabalin (150 mg twice a day) 
prevented the LH pain with the occipitocervical point 
pain left there unchanged.
Discussion
LH is a recently described headache pattern which appar-
ently constitutes a new headache syndrome or a new 
variant of migraine. Table 2 summarizes the main clinical 
features of the twenty LH cases that have been described 
so far: twelve cases in the original description by Wang 
et  al. (2014b) and eight new cases in the present com-
munication. Pareja et  al. reported another possible one 
but the clinical description is not full (Pareja and Ban-
dres 2015). Up to now, there has been a female predom-
inance (1.5:1), and the age at onset has ranged from 20 
to 73 years old (mean 41.8). LH is essentially character-
ized by episodic or chronic unilateral pain distributed 
in a linear trajectory of 5 mm to 10 mm in width, link-
ing one endpoint in occipital (60  %) or occipitocervical 
(40  %) region with another endpoint in ipsilateral nose 
(50 %), forehead (45 %) or parietal (5 %) region, and this 
linear trajectory is parallel to the sagittal midline of the 
head. In some patients, the pain is followed by ipsilat-
eral (10 %) or bilateral (5 %) temporal mild pain, nausea 
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with or without vomiting (30  %), dizziness (20  %), or 
photophobia/phonophobia (5  %). The episodic duration 
ranges mostly (90 %) from hours to days. Although some 
patients have a past history of migraine (15  %), there is 
no temporal relationship between the migraine headache 
and this newly described head pain. Painful episodes can 
be triggered by noise, depression, resting after physical 
activity (5 %), stress, staying up late (5 %) and menstrua-
tion (10 %). Pain frequency has varied widely from one to 
two attacks per month to four to five attacks per day. Two 
patients (patients 4 and 5 of our series) had persistent 
head pain for the symptomatic period of 1–6 months, but 
they also had episodic worsening of head pain within an 
unaltered distribution in a frequency of one time per day 
during the persistent symtomatic period.
There are several entities to which differential diagno-
sis need to be considered. EF, a recently described novel 
headache syndrome, is characterized by brief pain parox-
ysms starting in a particular area of the posterior scalp, 
and rapidly radiating forwards along a linear trajectory 
to reach the ipsilateral forehead, eye, or nose in a few 
seconds (Pareja et  al. 2008; Guerrero et  al. 2010; Cuad-
rado et al. 2013). The linear pain trajectory in EF is simi-
lar to that in LH, but LH is dramatically different from 
the ultrashort duration (less than 10  s) of moving stab-
bing or electric pain in EF patient. On the other hand, LH 
may be associated with EF. Pareja and Bandrés recently 
reported a patient with long-lasting linear interictal 
pain between the attacks of EF, and this interictal pain is 
similar to the LH pain (Pareja and Bandres, 2015). Wang 
et  al. have proposed that this linear interictal pain may 
be LH triggered by EF (Wang et al. 2015), as EF can trig-
ger the attacks of migraine and cluster headache (Jin and 
Wang, 2013), and LH has many clinical features similar to 
that of migraine (Wang et al. 2014b). Moreover, the LH 
pain area is correspondent to the scalp area innervated 
by the supraorbital nerve (SON) and the greater occipital 
nerve (GON), we need to differentiate LH from trigemi-
nal (TN) and occipital neuralgia (ON) and some trigemi-
nal autonomic cephalalgias (TACs) such as paroxysmal 
hemicrania (PH). But the much loner pain duration, the 
accompaniments of dizziness, and nausea, the trigger-
ing factors of noise, bright night, resting after physical 
activity and menstruation in LH makes it obviously dif-
ferent from TN and ON. PH is typically characterized by 
repeated attacks of severe, strictly unilateral pain lasting 
2–30 min, localized to orbital, supraorbital, and temporal 
areas accompanied by ipsilateral autonomic features of 
conjunctival, nasal, facial and eyelid symptoms or signs. 
But some atypical PH patients do not have accompani-
ment of autonomic symptoms and the pain duration may 
extend to hours (Boes and Dodick 2002; Maggioni 2010; 
Prakash et  al. 2013). This atypical episodic or chronic 
PH may have some LH-like features, but the LH pain 
striding the trigeminal and occopital nerve innervating 
areas is obviously different from the PH pain localized to 
orbital, supraorbital, and temporal areas or in any combi-
nation of these sites. These PH pain sites are innervated 
Table 2 Main features of the twenty patients with LH described to date
Wang et al. (n = 12) Current series (n = 8) Total (n = 20)
Female/male ratio 6/6 = 1:1 6/2 = 3:1 12/8 = 1.5:1
Mean age at onset (years) 40.6 ± 12.0 43.63 ± 17.51 41.8 ± 14.12
Age range at onset (years) 20–73 32–74 20–74
Severity of pain Moderate to severe Moderate to severe Moderate to severe
Pain character
Pressure‑like 3:12 = 25 % 1:8 = 12.5 % 4:20 = 20 %
Distending/stretching 7:12 = 58.3 % 3:8 = 37.5 % 10:20 = 50 %
Throbbing/pulsating 3:12 = 25 % 4:8 = 50 % 6:20 = 30 %
Accompaniments
Nausea 6:12 = 50 % 2:8 = 25 % 8:20 = 40 %
Diziness 2:12 = 16.7 % 2:8 = 25 % 4:20 = 20 %
Photophobia 0 % 1:8 = 12.5 % 1:20 = 5 %
Phonophobia 0 % 1:8 = 12.5 % 1:20 = 5 %
Episode duration (range)
Less than 2 h 3:12 = 25 % 2:8 = 25 % 7:20 = 35 %
Half day (2–10 h) 5:12 = 41.7 % 3:8 = 37.5 % 7:20 = 35 %
1 day (10–24 h) 4:12 = 33.3 % 1:8 = 12.5 % 6:20 = 30 %
More than 1 day (>24 h) 4:12 = 33.3 % 3:8 = 37.5 % 7:20 = 35 %
Triggers 2:12 = 16.7 % 4:8 = 50 % 6/20 = 30 %
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by trigeminal nerve only, as PH is a type of trigeminal 
cephalalgia. Thus, LH is different from PH in headache 
classification.
CEH has rarely been described as pain distributing in 
a line-shaped area (Cooper et al. 2007) and, in rare cases, 
it may be accompanied with photophoboa, phonophobia, 
dizziness or nausea (Hall et al. 2010b). This clinical char-
acteristics are similar to that of LH, thus, we need to dif-
ferentiate LH from CEH. In fact, there are many different 
characteristics between LH and CEH. First, the CEH pain 
attack starts in the neck, eventually spreads to the oculo-
frontotemporal area (Sjaastad et al. 1990, 1998; Antonaci 
et al. 2006), but the pain in LH is fixed, and the one end-
point of pain trajectory in LH is not the oculofronto-
temporal area but a point in nasion or forehead region, 
another endpoint is not the neck but a point in occipi-
tal or occipitocervical region. Second, CEH has been 
defined, in principle, as a unilateral headache without 
sideshift (Antonaci et al. 2006), but the sideshift of pain 
exists in two out of twenty LH patients (20  %), indicat-
ing that the pain sideshift is not uncommon in LH. Third, 
menstrual-type headaches may uncommonly be cervico-
genic (Lieba-Samal and Wober 2011), a study indicated 
that one out of one hundred (1  %) cases of menstrual-
type headaches was cervicogenic headache (Miziara et al. 
2003). In our series of LH patients, two out of twenty 
(10  %) patients had menstrual-type headache, indicat-
ing that menstrual-type headache is not uncommonly 
LH type. Fourth, the FRT was positive only in one out of 
eight LH patients (12.5 %), but positive in fourteen out of 
twenty CEH patients (70  %) (Hall et  al. 2010b). Hereby, 
we may conclude that LH is significantly different from 
CEH, and this is further supported by its well response to 
flunarizine and sodium valproate which had never been 
shown effective in CEH. Finally, the literature-reported 
CEH with pain restricted in a line-shaped area (Cooper 
et al. 2007) may, in fact, be LH but not CEH, as the exclu-
sive diagnostic measure was anesthetic blockades at 
upper cervical spinal nerves (Cooper et al. 2007), and the 
anesthetic blockade of the branch of upper cervical spinal 
nerves, occipital nerve, was also effective in many other 
types of headaches including migraine headache (Dilli 
et al. 2015; Inan et al. 2015).
A special head pain that is defined with topographi-
cal criteria, nummular headache (NH), may need to be 
differentiated with LH, as LH is also defined with topo-
graphical criteria. NH was first described by Pareja et al. 
in 2002 (Pareja et al. 2002). NH is a continuous or inter-
mittent pain which is commonly described as oppressive 
and felt circumscribed within a rounded or elliptical area, 
typically 1 cm to 6 cm in diameter (Pareja et al. 2002; IHS 
2013). Nevertheless, some NH patients show atypical fea-
tures resembling a migraine pattern such as episodic pain 
accompanied with nausea, photophobia and phonophobia 
(Dai et al. 2013), triggered by or aggravated with physical 
exercise (Mulero et al. 2013; Baron et al. 2015), or related 
to menstruation (Robbins and Grosberg, 2010). Some 
LH patients complained a paroxymal or continuous pain 
of oppressive, distending or throbbing features with no 
accompanied symptom, while some other LH patients 
showed pain features resembling a migraine pattern such 
as episodic pain accompanied with nausea, photophobia 
and phonophobia, triggered by or aggravated with physi-
cal exercise, or related to menstruation. Given the LH is a 
special type of NH, the linear pain area may be explained 
as an extension of a rounded or elliptical pain area of NH. 
And this hypothesis is seemly supported by reports show-
ing that NH pain can affect multiple rounded areas on the 
head simutaneously (Cuadrado et al. 2009; Porta-Etessam 
et  al. 2010; Guerrero et  al. 2011; Rodriguez et  al. 2015). 
Thus, a connection of series of NH pain areas may form 
a line-shaped pain area as described in LH, otherwise, the 
small NH rounded pain area with a diameter of 1 cm or 
shorter may expand in one direction forming a line-shaped 
area, 5–10  mm in width as described in LH, or expand 
in all directions forming a large rounded area, 6–8 cm in 
diameter as reported in NH (Man et al. 2012; IHS 2013). 
Whereas, it is hard to explain how the pain affected a line-
shaped area parallel to the saggital midline of the head in 
all LH patients, while the pain area can be localized in any 
part of the head though mostly in the parietal region in 
NH patients (Pareja et al. 2012). Thus, it is hard to consider 
LH as a variant of NH, and on the other hand, the thera-
peutic responses of LH patients to anti-migraine agents do 
not suggest that LH presents as a variant of NH either.
The first case of LH pain was reported with accompa-
niment of ophthalmoplegia successive to the episodic 
line-shaped head pain which had couple of features simi-
lar to that of migraine pattern, such as past history of 
recurrent migraine attacks, accompaniments of nausea, 
vomiting, and phonophobia, response to anti-migraine 
therapy. The presentations of this case are suggestive of a 
subtype of ophthalmoplegic migraine (OM) (Wang et al. 
2014a) though the term of OM had been replaced by 
recurrent painful ophthalmoplegic neuropathy (RPON) 
in the 3rd edition of the International Headache Classi-
fication (ICHD-3) (IHS 2013). This case of ophthalmo-
plegic LH indicates that LH is closely related to migraine 
or probably exists as a variant of migraine. From the cur-
rent and previous LH case series, plenty of similarities 
can be found between LH and migraine in clinical fea-
tures including female to male ratio, pulsating and pres-
sure-like pain quality, moderate to severe pain severity, 
accompaniments of nausea and dizziness, triggering fac-
tors, average episode durations and treatment responses 
to anti-migraine therapy as summarized in Table  3. 
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Furthermore, menstruation-related headaches are pre-
dominately migraine or tension type headache (TTH) but 
scarcely CGH (Karli et al. 2012). In our current and pre-
vious case series, two out of twenty had menstruation-
related headache, indicating that menstruation-related 
headache is not uncommon in LH patients, and our LH 
headaches are of course not TTH as TTH has never been 
reported to have pain distribution in a line-shaped area. 
Further, among the patients of menstrual headaches, 
88 % patients are those with migraine without aura (Miz-
iara et al. 2003). Thus, the LH pain is more suggested to 
be related to migraine. Nevertheless, many differences 
of great significance also exist between LH and migraine 
as summarized in Table 3. First, the mean age at onset of 
LH (41.8 ±  14.12  year old) is obviously older than that 
of migraine (22 ± 15 year old) and all the LH onset is at 
adult but the migraine onset commonly at child age. Sec-
ond, the pain quality of distending or stretching is much 
more common (50 %) in LH than that in migraine (9.7 %). 
Third, accompaniment of photophobia or phonopho-
bia is rare in LH (5, 5 %) but common in migraine (51.9, 
58.7 %). In fact, the features of the head pain fulfilling the 
diagnostic criteria for migraine without aura were found 
only in six patients (patients 2, 4, 6, 9, 11 and 12) of the 
previous series and in three patients (patients 5, 7 and 
8) of the current series, if we treated the unilateral line-
shaped head pain as unilateral headache, one of the char-
acter for migraine diagnosis (IHS 2013). Thus, LH may 
represent a new headache syndrome but not a variant of 
migraine.
Table 3 Comparison between Linear Headache (LH) from twenty patients and Migraine from literature in demographic 
and clinical features
a Apart from the references indicated in migraine column, all other data in this column are from reference (Murtaza et al. 2009)
Migraine (Murtaza et al. 2009)a Linear headache
Mean age at onset (years) 22 ± 15 41.8 ± 14.12
Age range at onset (years) 6–65 20–73
Female/Male ratio 141/65 = 2.16:1 12/8 = 1.5:1
Severity of pain Moderate to severe (Kelman, 2006) Moderate to severe
Pain character
Pressure‑like 23.8 % 4:20 = 20 %
Distending/stretching 9.7 % 10:20 = 50 %
Throbbing/pulsating 31.6 % 6:20 = 30 %
Accompaniments
Nausea 57.8 % 8:20 = 40 %
Vomiting 32 % 4:20 = 20 %
Diziness 17 % 4:20 = 20 %
Photophobia 51.9 % 1:20 = 5 %
Phonophobia 58.7 % 1:20 = 5 %
Average episode duration (h)
Less than 2 h 23.4 % 7:20 = 35 %
Half day (2–10 h) 41.4 % 7:20 = 35 %
1 day (10–24 h) 14.1 % 6:20 = 30 %
More than 1 day (>24 h) 21.1 % 7:20 = 35 %
Triggered by
Noise, bright night, depression, fatigue and resting after 
physical activity
Yes Yes
Stress, staying up late Yes Yes
Menstruation Common (Miziara et al. 2003) Common
Treatment requirement Approximate half patients (MacGregor et al. 2003) Most cases
Treatment
Response to flunarizine Most patients (Luo et al. 2012) Common
Response to sodium valproate Most patients (MacGregor et al. 2003), and recommendation with level A 
evidence (Silberstein et al. 2012)
Common
Response to carbamazepine Possibably effective in some patients with no new evidence (Silberstein 
et al. 2012)
No response
Response to oxcarbazepine No response (Silberstein et al. 2008) No response
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Regarding the pathogenesis of LH, it is unknown, but 
a migraine headache mechanism might be employed to 
comprehend it based on the similarities between LH and 
migraine in clinical features. In the original publication 
of LH case series, it is proposed that a line-shaped area 
of meningeal nociceptors parallel to the superior sagit-
tal sinus (SSS) is more prone to be activated by cortical 
spreading depression (CSD) due to the sensitization of 
meningeal nociceptors caused by immuno-vascular inter-
actions (Levy 2012). This results in a line-shaped cepha-
lalgia through migraine pain pathway, as CSD-induced 
long-lasting activation of meningeal nociceptors inner-
vated by the fibers of SON or GON has been accepted 
to be one of the original migraine pathophysiological 
processes leading to the activation of central trigemino-
vascular neurons in the spinal trigeminal nucleus (C1-2) 
underlying migraine headache (Zhang et  al. 2010; Zhao 
and Levy 2015). This proposed pathogenesis related to 
CSD is seemly supported by the effective responses to 
anti-migraine drugs of flunarizine, venlafaxine, and anti-
epileptic drug of sodium valproate which had been shown 
able to suppress CSD (Wauquier et al. 1985; Ayata et al. 
2006) or reduce depolarization-evoked glutamate release 
(Musazzi et al. 2010; Milanese et al. 2013), basis of CSD 
which is a common therapeutic target for currently pre-
scribed migraine prophylactic drugs (Costa et  al. 2013). 
This proposed pathogenesis is further supported by our 
recent case study of a woman who had a recurrent head 
pain circumscribed in a coronal line-shaped area around 
the head, a coronal LH. Similar to the LH pain area close 
and parallel to the sagittal venous sinus, SSS, this coronal 
LH pain area is close and parallel to a coronal cambered 
venous sinus complex, the combination of the confluens 
of sinus (CFS) and the bilateral cavernous sinus (CS), 
superior petrosal sinus (SPS) linking the CS with trans-
verse sinus (TS) and TS into which the SPS feeds (Wang 
et al. 2016), Whereas, this proposed pathogenesis under-
lying LH is pure speculation, further observations of its 
clinical characteristics and pathophysiological studies are 
required to clarify it. For example, studies of the cerebral 
excitability in LH in comparision with that in migraine 
without aura in human and studies of venous sinus 
endophlebitis-induced activation of neurons in the spi-
nal nociceptive center, the trigeminocervical complex, in 
animal model may be helpful to clarify the pathogenesis 
of LH. On the other hand, trials of more medications of 
different pharmacological mechanisms may also be help-
ful, and this depends on collection of much more cases. 
In fact, the limitation of our current study report is the 
small size of case collection and medication trials.
Conclusions
The current LH cases and those originally described 
show a clear-cut clinical picture. LH is basically char-
acterized by recurrent or chronic unilateral pain cir-
cumscribed in a line-shaped area linking one endpoint 
in occipital or occipitocervical region with another one 
endpoint in ipsilateral nose or forehead region, accom-
panied with or without nausea, vomiting, dizziness and 
mild temporal pain. So far, anti-migraine therapies have 
been shown effective in individual patients. This report 
reinforces the proposal that LH is a new headache syn-
drome or a new variant of previously known headache 
syndrome, probably of migraine. Most patients require 
therapeutic measures. At this stage, no definite explana-
tion can be provided, but the clinical features point to a 
pathophysiological pathway similar to that of migraine. 
Further observations and pathophysiological studies are 
required for a definitive characterization and compre-
hension of this headache.
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